514
Participants
Start Date
June 21, 2021
Primary Completion Date
April 11, 2023
Study Completion Date
April 11, 2023
HEC74647PA+HEC110114
administered orally once daily for 12 weeks
Placebo
administered orally once daily for 12 weeks
Peking University People's Hospital, Beijing
Beijing Tsinghua Changgung Hospital, Beijing
The First Affiliated Hospital of Bengbu Medical College, Bengbu
The Second Hospital of Anhui Medical University, Hefei
Anhui Provincial Hospital, Hefei
The 900th Hospital of the Joint Logistics Support Force Hospital, Fuzhou
Foshan First People's Hospital, Foshan
Guangzhou Eighth People's Hospital, Guangzhou
Nanfang Hospital of Southern Medical University, Guangzhou
Hainan Provincial People's Hospital, Haikou
The Third Hospital of Hebei Medical University, Shijiazhuang
Wuhan University People's Hospital, Wuhan
The Fourth Affiliated Hospital of Harbin Medical University, Haerbin
Luoyang Central Hospital, Luoyang
The First Affiliated Hospital of Xinxiang Medical College, Xinxiang
Henan Infectious Diseases Hospital, Zhengzhou
Henan Provincial People's Hospital, Zhengzhou
Zhengzhou People's Hospital, Zhengzhou
Hunan Provincial People's Hospital, Changsha
Xiangya Hospital Central South University, Changsha
The First Affiliated Hospital of South China, Hengyang
The First People's Hospital of Lianyungang, Lianyungang
Jiangsu Provincial Hospital, Nanjing
Nanjing Second Hospital, Nanjing
Wuxi No.5 People's Hospital, Wuxi
The Affiliated Hospital of Xuzhou Medical University, Xuzhou
Zhenjiang Third People's Hospital, Zhenjiang
The First Affiliated Hospital of Nanchang University, Nanyang
The First Hospital of Jilin University, Changchun
Tonghua Central Hospital, Tonghua
Yanbian University Hospital, Yanbian
The Sixth People's Hospital Of Shenyang, Shenyang
Qingdao Municipal Hospital, Qingdao
Huashan Hospital of the Fudan University, Shanghai
Tianjin Third Central Hospital, Tianjin
Beijing You'an Hospital,Capital Medical University, Beijing
Sunshine Lake Pharma Co., Ltd.
INDUSTRY